Previous 10 | Next 10 |
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief exe...
Gainers: LMP Automotive (NASDAQ: LMPX ) +95% . More news on: LMP Automotive Holdings, Inc., Sarepta Therapeutics, Inc., Cohen & Company Inc., Stocks on the move, Read more ...
Successful completion of human factors program ahead of FUROSCIX NDA resubmission scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient ca...
The following slide deck was published by scPharmaceuticals Inc. in conjunction with this Read more ...
Gainers: Paringa Resources (NASDAQ: PNRL ) +250% . More news on: Paringa Resources Limited, ASLAN Pharmaceuticals Limited, Hepion Pharmaceuticals, Inc., Stocks on the move, Read more ...
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive office...
The following slide deck was published by scPharmaceuticals Inc. in conjunction with this Read more ...
BURLINGTON, Mass., Nov. 14, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, t...
scPharmaceuticals (NASDAQ: SCPH ): Q3 GAAP EPS of -$0.33 beats by $0.10 . More news on: scPharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Continued progress on FUROSCIX ® ; confirming the planned resubmission of FUROSCIX ® NDA with the FDA by mid-year 2020 remains on track Company initiated the second of two planned human factors studies Completed $20.0 million term loan with Solar Capital Ltd. and Sili...
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...
Generated 1Q 2024 net FUROSCIX ® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 with cash and cash equivalents o f $58.4 million Company to host investor conference call and web...